- Home
- Publications
- Publication Search
- Publication Details
Title
Impaired brain insulin signalling in Parkinson's disease
Authors
Keywords
-
Journal
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2021-08-18
DOI
10.1111/nan.12760
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Novel Dual GLP-1/GIP Receptor Agonist DA-CH5 Is Superior to Single GLP-1 Receptor Agonists in the MPTP Model of Parkinson’s Disease
- (2020) Lingyu Zhang et al. Journal of Parkinsons Disease
- Insulin Sensitivity in De Novo Parkinson's Disease: A Hyperinsulinemic‐Euglycemic Clamp Study
- (2020) N. Ahmad Aziz et al. MOVEMENT DISORDERS
- Peripheral insulin and amylin levels in Parkinson's disease
- (2020) Almudena Sánchez-Gómez et al. PARKINSONISM & RELATED DISORDERS
- GLP-1’s role in neuroprotection: a systematic review
- (2019) Damla Erbil et al. BRAIN INJURY
- Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson’s disease
- (2018) Seung Pil Yun et al. NATURE MEDICINE
- High Prevalence of Undiagnosed Insulin Resistance in Non-Diabetic Subjects with Parkinson’s Disease
- (2018) Elliot Hogg et al. Journal of Parkinsons Disease
- Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial
- (2017) Dilan Athauda et al. LANCET
- Brain Insulin-Like Growth Factor and Neurotrophin Resistance in Parkinson's Disease and Dementia with Lewy Bodies: Potential Role of Manganese Neurotoxicity
- (2017) Ming Tong et al. JOURNAL OF ALZHEIMERS DISEASE
- Multi-facetted impulsivity following nigral degeneration and dopamine replacement therapy
- (2016) Michel Engeln et al. NEUROPHARMACOLOGY
- Dysfunctionally phosphorylated type 1 insulin receptor substrate in neural-derived blood exosomes of preclinical Alzheimer’s disease
- (2015) Dimitrios Kapogiannis et al. FASEB JOURNAL
- Alpha-synuclein overexpression negatively regulates insulin receptor substrate 1 by activating mTORC1/S6K1 signaling
- (2015) Shanshan Gao et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Glycogen synthase kinase-3 beta (GSK-3β) signaling: Implications for Parkinson's disease
- (2015) Mojtaba Golpich et al. PHARMACOLOGICAL RESEARCH
- Motor and Cognitive Advantages Persist 12 Months After Exenatide Exposure in Parkinson’s Disease
- (2015) Iciar Aviles-Olmos et al. Journal of Parkinsons Disease
- Lack of additive role of ageing in nigrostriatal neurodegeneration triggered by α-synuclein overexpression
- (2015) Mathieu Bourdenx et al. Acta Neuropathologica Communications
- Abnormal serine phosphorylation of insulin receptor substrate 1 is associated with tau pathology in Alzheimer’s disease and tauopathies
- (2014) Mark Yarchoan et al. ACTA NEUROPATHOLOGICA
- Insulin, IGF-1 and GLP-1 signaling in neurodegenerative disorders: Targets for disease modification?
- (2014) Fares Bassil et al. PROGRESS IN NEUROBIOLOGY
- Levodopa gains psychostimulant-like properties after nigral dopaminergic loss
- (2013) Michel Engeln et al. ANNALS OF NEUROLOGY
- Exenatide and the treatment of patients with Parkinson’s disease
- (2013) Iciar Aviles-Olmos et al. JOURNAL OF CLINICAL INVESTIGATION
- Insulin-like growth factor-1 and progression of motor symptoms in early, drug-naïve Parkinson’s disease
- (2013) Marina Picillo et al. JOURNAL OF NEUROLOGY
- An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer’s disease–associated Aβ oligomers
- (2012) Theresa R. Bomfim et al. JOURNAL OF CLINICAL INVESTIGATION
- Demonstrated brain insulin resistance in Alzheimer’s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline
- (2012) Konrad Talbot et al. JOURNAL OF CLINICAL INVESTIGATION
- 100 years of Lewy pathology
- (2012) Michel Goedert et al. Nature Reviews Neurology
- Serum Insulinlike Growth Factor 1 as Possible Marker for Risk and Early Diagnosis of Parkinson Disease
- (2011) Jana Godau ARCHIVES OF NEUROLOGY
- Direct Interaction of α-Synuclein and AKT Regulates IGF-1 Signaling: Implication of Parkinson Disease
- (2011) Ji-Yun Chung et al. NEUROSIGNALS
- Expression of insulin-like growth factor-1 and insulin-like growth factor binding proteins in the serum and cerebrospinal fluid of patients with Parkinson’s disease
- (2010) Farhad Mashayekhi et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Increased serum insulin-like growth factor 1 in early idiopathic Parkinson's disease
- (2010) J. Godau et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Pathogenic Lysosomal Depletion in Parkinson's Disease
- (2010) B. Dehay et al. JOURNAL OF NEUROSCIENCE
- Insulin like growth factor-1 prevents 1-mentyl-4-phenylphyridinium-induced apoptosis in PC12 cells through activation of glycogen synthase kinase-3beta
- (2010) Xin Sun et al. TOXICOLOGY
- Cell death pathways in Parkinson’s disease: proximal triggers, distal effectors, and final steps
- (2009) Oren A. Levy et al. APOPTOSIS
- Rescue of α-synuclein cytotoxicity by insulin-like growth factors
- (2009) Shyan-Yuan Kao BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Dopamine promotes striatal neuronal apoptotic death via ERK signaling cascades
- (2009) Jun Chen et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Alterations in lysosomal and proteasomal markers in Parkinson's disease: Relationship to alpha-synuclein inclusions
- (2009) Yaping Chu et al. NEUROBIOLOGY OF DISEASE
- PI3 kinase/Akt activation mediates estrogen and IGF-1 nigral DA neuronal neuroprotection against a unilateral rat model of Parkinson's disease
- (2008) Arnulfo Quesada et al. Developmental Neurobiology
- Parkinson's disease: clinical features and diagnosis
- (2008) J Jankovic JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling
- (2008) Aileen M. Moloney et al. NEUROBIOLOGY OF AGING
- Human neural progenitor cells over-expressing IGF-1 protect dopamine neurons and restore function in a rat model of Parkinson's disease
- (2007) Allison D. Ebert et al. EXPERIMENTAL NEUROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started